The influence of pharmacist-led collaborative care on clinical outcomes in type 2 diabetes mellitus: a multicenter randomized control trial
- PMID: 38476498
- PMCID: PMC10929610
- DOI: 10.3389/fpubh.2024.1323102
The influence of pharmacist-led collaborative care on clinical outcomes in type 2 diabetes mellitus: a multicenter randomized control trial
Abstract
Background: Health care providers are mandated to deliver specialized care for the treatment and control of type 2 diabetes mellitus. In Malaysia, Diabetes Medication Therapy Adherence Clinics (DMTAC) in tertiary hospitals have designated pharmacists to administer these services.
Objective: To assess the effects of pharmacist-led interventions within DMTAC on the outcomes of patients with type 2 diabetes mellitus in two distinct hospitals in Kedah, Malaysia.
Methods: Patients with type 2 diabetes were randomly selected from the two hospitals included in this study. The study population was divided into two equal groups. The control group consisted of 200 patients receiving routine care from the hospitals. On the other hand, the intervention group included those patients with type 2 diabetes (200), who received separate counseling sessions from pharmacists in the DMTAC departments along with the usual treatment. The study lasted 1 year, during which both study groups participated in two distinct visits.
Results: Parametric data were analyzed by a paired t-test and one-way ANOVA, while non-parametric data were analyzed by a Chi-squared test using SPSS v24. A p < 0.05 was considered statistically significant. The study presented the results of a greater reduction in HBA1c levels in the intervention group compared to the control group, i.e., 3.59 and 2.17% (p < 0.001). Moreover, the Systolic and Diastolic values of BP were also significantly reduced in the intervention group, i.e., 9.29 mmHg/7.58 mmHg (p < 0.005). Furthermore, cholesterol levels were significantly improved in patients in the intervention group, i.e., 0.87 mmol/L (p < 0.001).
Conclusion: Based on the findings of the current study it has been proven that the involvement of pharmacists leads to improved control of diabetes mellitus. Therefore, it is recommended that the government initiate DMTAC services in both private and government hospitals and clinics throughout Malaysia. Furthermore, future studies should assess the impact of pharmacist interventions on other chronic conditions, including but not limited to asthma, arthritis, cancer, Alzheimer's disease, and dementia.
Keywords: DMTAC clinics; HBA1c; blood pressure; control group; diabetes mellitus-type 2; intervention group; lipid profile.
Copyright © 2024 Iqbal, Alqahtani, Mubarak, Shahid, Mohammed, Mustafa, Khan and Iqbal.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Impact of Pharmacist Educational Intervention on Costs of Medication with Improved Clinical Outcomes for Diabetic Patients in Various Tertiary Care Hospitals in Malaysia: A Randomized Controlled Trial.Healthcare (Basel). 2025 Apr 14;13(8):901. doi: 10.3390/healthcare13080901. Healthcare (Basel). 2025. PMID: 40281848 Free PMC article.
-
Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia.Pak J Pharm Sci. 2016 Mar;29(2):595-601. Pak J Pharm Sci. 2016. PMID: 27087103 Clinical Trial.
-
The impact of pharmacist interventions, follow-up frequency and default on glycemic control in Diabetes Medication Therapy Adherence Clinic program: a multicenter study in Malaysia.J Pharm Policy Pract. 2023 Jul 5;16(1):83. doi: 10.1186/s40545-023-00583-8. J Pharm Policy Pract. 2023. PMID: 37408067 Free PMC article.
-
Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.J Manag Care Spec Pharm. 2016 May;22(5):493-515. doi: 10.18553/jmcp.2016.22.5.493. J Manag Care Spec Pharm. 2016. PMID: 27123912 Free PMC article.
-
Impact of Pharmacist-Led Interventions to Improve Clinical Outcomes for Adults With Type 2 Diabetes at Risk of Developing Cardiovascular Disease: A Systematic Review and Meta-analysis.J Pharm Pract. 2023 Aug;36(4):888-899. doi: 10.1177/08971900211064459. Epub 2022 May 17. J Pharm Pract. 2023. PMID: 35579209 Free PMC article.
Cited by
-
Impact of Pharmacist Educational Intervention on Costs of Medication with Improved Clinical Outcomes for Diabetic Patients in Various Tertiary Care Hospitals in Malaysia: A Randomized Controlled Trial.Healthcare (Basel). 2025 Apr 14;13(8):901. doi: 10.3390/healthcare13080901. Healthcare (Basel). 2025. PMID: 40281848 Free PMC article.
-
Effectiveness of Pharmacist-Led Intervention on Medication Adherence in Chronic Diseases: A Systematic Review of Randomized Controlled Trials.Patient Prefer Adherence. 2025 Jul 22;19:2161-2178. doi: 10.2147/PPA.S530503. eCollection 2025. Patient Prefer Adherence. 2025. PMID: 40726768 Free PMC article. Review.
-
Drug-related problems among type 2 diabetic patients in Sunwal Municipality of Western Nepal.PLoS One. 2024 Nov 21;19(11):e0309781. doi: 10.1371/journal.pone.0309781. eCollection 2024. PLoS One. 2024. PMID: 39570842 Free PMC article.
-
Randomized controlled trial parallel-group on optimizing community pharmacist's care for the elderly: The influence of WhatsApp-Email delivered clinical case scenarios.PLoS One. 2024 Oct 22;19(10):e0308448. doi: 10.1371/journal.pone.0308448. eCollection 2024. PLoS One. 2024. PMID: 39436887 Free PMC article. Clinical Trial.
References
-
- Ab Majid NL, Omar MA, Khoo YY, Mahadir Naidu B, Ling Miaw Yn J, Rodzlan Hasani WS, et al. . Prevalence, awareness, treatment and control of hypertension in the Malaysian population: findings from the National Health and Morbidity Survey 2006–2015. J Hum Hypertens. (2018) 32:617–24. doi: 10.1038/s41371-018-0082-x, PMID: - DOI - PMC - PubMed
-
- Abd Manaf NH, Omar A, Omar MA, Salleh M. Determinants of healthcare utilisation among the elderly in Malaysia. Instit Econ. (2017) 9:115–40.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical